On July 20, 2026, Veracyte Inc VCYT shares fell 3.2% today to a current price of $57.26. Over the past year, the stock has exhibited significant volatility, reaching a 52-week high of $60.91 and a low of $22.61.
- GF Valueâ„¢ verdict: Current price is $57.26, compared to GF Valueâ„¢ of $38.35, indicating the stock is 49.3% overvalued.
- GF Scoreâ„¢: 75/100, which is classified as above average.
- Most notable signal: Insiders sold $10.1M in the last 3 months with no insider buying activity.
Is VCYT Overvalued or Undervalued?
Veracyte Inc is currently assessed as overvalued based on the GF Valueâ„¢, which estimates the fair value of the stock at $38.35. With the current trading price at $57.26, this represents a significant 49.3% premium to the fair value estimate. Such a gap suggests a lack of margin of safety for potential investors, as the current price does not reflect a conservative investment approach. The GF Valuation label indicates that the stock is significantly overvalued, which raises concerns about the sustainability of its current price level.
The risk involved with investing in an overvalued stock like VCYT is that market corrections could occur, potentially leading to a sharp decline in share price. A stock trading significantly above its intrinsic value may be subject to increased volatility and investor sentiment shifts, particularly if future performance does not meet market expectations.
GF Valueâ„¢ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates.
How Does VCYT's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | 52.5x | 74.0x |
| Forward P/E | 52.7x | N/A |
Currently, Veracyte's P/E (TTM) stands at 52.5x, which is 29% below its 5-year median P/E of 74.0x. This indicates that the stock is trading at a lower valuation multiple compared to its historical average, suggesting it may not be as overpriced based on historical standards. However, this P/E analysis aligns with the GF Valueâ„¢ verdict, supporting the conclusion that VCYT is still overvalued given the discrepancy between its trading price and the calculated fair value.
What Does VCYT's GF Scoreâ„¢ Tell Us?
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 75 |
| Financial Strength | 8/10 |
| Profitability | 4/10 |
| Growth | 8/10 |
| Valuation | 3/10 |
| Momentum | 9/10 |
The GF Scoreâ„¢ of 75/100 indicates that Veracyte Inc has an above-average overall rating, with its strongest areas being financial strength (8/10) and growth (8/10). However, profitability (4/10) and valuation (3/10) are notably weaker, suggesting that while the company is strong financially and has good growth prospects, it may not be generating high profits relative to its valuation, contributing to the overvaluation signal from GF Valueâ„¢.
What Are Insiders Doing with VCYT Stock?
In the past three months, insiders at Veracyte Inc have sold a substantial amount of stock, totaling $10.1 million, with no reported insider buying during the same period. This trend may suggest a lack of confidence from insiders regarding the company's future prospects at the current valuation. Such selling activity can often raise red flags for potential investors, as it may indicate that those closest to the company do not believe the stock price accurately reflects its future potential.
What This Means for Investors
Based on the analysis, Veracyte Inc VCYT is currently overvalued according to the GF Valueâ„¢ assessment. This indicates that caution may be warranted for potential investors considering an entry point at the current price levels.
For the complete analysis, visit the Veracyte Inc VCYT stock page. You can also explore the GF Valueâ„¢ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is VCYT's GF Scoreâ„¢?
VCYT has a GF Scoreâ„¢ of 75/100, indicating it is rated above average in terms of potential long-term returns based on various financial metrics.
Is VCYT overvalued or undervalued?
VCYT is currently overvalued, with a GF Valueâ„¢ of $38.35 compared to the current price of $57.26, indicating a significant premium.
What is VCYT's P/E ratio?
VCYT has a P/E (TTM) ratio of 52.5x, which is 29% below its 5-year median P/E of 74.0x, suggesting it is trading at a lower valuation compared to its historical performance.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
